Literature DB >> 6304891

[Gilles de la Tourette's disease].

A Lipcsey.   

Abstract

The case of a seventeen-year-old girl in whom typical particularly disabling Gilles de la Tourette syndrome had developed three years earlier is reported. The usual therapeutic agents (benzodiazepines, clomethiazole, paraldehyde, choline chloride) had proved totally or partially ineffective. Under 300 mg of tiapride per day given intramuscularly, the hyperkinesia and phonatory tics resolved rapidly. Conversion to a daily dosage of 900 mg of tiapride given orally ensured the permanence of this improvement and the patient was able to resume a nearly normal life.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6304891

Source DB:  PubMed          Journal:  Sem Hop


  3 in total

Review 1.  [The benzamides tiapride, sulpiride, and amisulpride in treatment for Tourette's syndrome].

Authors:  K R Müller-Vahl
Journal:  Nervenarzt       Date:  2007-03       Impact factor: 1.214

2.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

3.  Update on the role of antipsychotics in the treatment of Tourette syndrome.

Authors:  Daniel Huys; Katja Hardenacke; Pia Poppe; Christina Bartsch; Burak Baskin; Jens Kuhn
Journal:  Neuropsychiatr Dis Treat       Date:  2012-03-12       Impact factor: 2.570

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.